Alterations in the PI3K Pathway Drive Resistance to MET Inhibitors in NSCLC Harboring MET Exon 14 Skipping Mutations
Philippe Jamme, Marie Fernandes, Marie‐Christine Copin, C. Descarpentries, Fabienne Escande, Angela Morabito, V. Grégoire, Matthieu Jamme, Simon Baldacci, David Tulasne, Zoulika Kherrouche, Alexis B. Cortot
Topics & Concepts
PTENPI3K/AKT/mTOR pathwayTensinCancer researchMedicineP110αKRASPhosphoinositide 3-kinaseSignal transductionBiologyCancerInternal medicineCell biologyColorectal cancerPI3K/AKT/mTOR signaling in cancerLung Cancer Treatments and MutationsLiver physiology and pathology